Laerdal Medical, a global leader in healthcare simulation solutions, is excited to unveil its exclusive worldwide distribution partnership with SIMCharacters, an Austrian company specializing in neonatal simulation technology.
As of April 1st, 2024, Laerdal will be the sole global distributor for SIMCharacters’ products, including “Paul,” an advanced premature simulator noted for its high-emotion simulation capabilities, and “Emily,” a full-term simulator introduced at IMSH 2024.
Leveraging Laerdal’s extensive global Sales, Marketing & Services (SMS) organization, this collaboration aims to amplify the reach of SIMCharacters’ life-saving simulators. The addition of Paul and Emily to Laerdal’s portfolio aligns seamlessly with the needs of healthcare professionals worldwide, enhancing training capabilities for neonatal care.
“We’re thrilled to embark on this partnership with SIMCharacters,” said Alf-Christian Dybdahl, CEO at Laerdal Medical. “The synergy between SIMCharacters’ innovative products and our global reach positions us to better serve the healthcare community by delivering impactful simulation solutions.”
“My journey into neonatal simulation began in 2006 in Stavanger when Laerdal introduced its first newborn simulator. For me personally, the collaboration with Laerdal comes full circle. Our entire team of engineers, hardware and software developers, special effects designers, neonatologists, and neonatal nurses, is delighted about the cooperation with Laerdal to improve the quality of care jointly and sustainably for critically ill preterm and newborn infants,” said Jens-Christian Schwindt, CEO and Founder, SIMCharacters.
As the distribution agreement sets the foundation for a deeper collaboration, Laerdal and SIMCharacters aim to explore additional opportunities throughout the first quarter of 2024. Together, they aspire to maximize their strengths to drive innovation and enhance healthcare quality, ultimately contributing to improved patient outcomes globally.
